Evaluating kidney injury after contrast procedures at Sohag University Hospitals
Official title: Study of Contrast - Induced Nephropathy After Intravenous Contrast Procedures at Sohag University Hospitals
Run by Sohag University · NCT06965764 · Data updated 2026-11-12
This study looks at how often kidney problems happen after patients receive contrast dye during medical procedures at Sohag University Hospitals, especially in those who may be at higher risk.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | Men only |
| Enrollment | 200 (estimated) |
| Sponsor | Sohag University Academic / other |
| Locations | 2 sites (Sohag and 1 other locations) |
| Status | Recruiting |
| Started | March 12, 2025 |
| Main results expected | September 12, 2025 |
| Study ends | September 12, 2025 |
| Registry record updated | May 14, 2025 |
| Trial ID | NCT06965764 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are inpatients and outpatients aged 18 years and older who have undergone a single intravenous contrast procedure.
✕Probably not a fit
Patients under 18 years, those with end-stage renal disease, or those with severe cardiac failure are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study investigates the occurrence of contrast-induced nephropathy (CIN) following intravenous contrast procedures at Sohag University Hospitals. CIN is a significant complication that can lead to acute renal injury, particularly in patients with certain risk factors such as diabetes or pre-existing renal insufficiency. The study aims to assess the incidence of CIN in both inpatients and outpatients aged 18 and older who have undergone these procedures. By analyzing the rise in serum creatinine levels post-contrast exposure, the study seeks to better understand the risk factors associated with CIN.
Why it matters
Potential benefit: If successful, this study could help identify at-risk patients and improve strategies to prevent contrast-induced nephropathy.
How similar studies have gone: Other studies have shown varying success in understanding and preventing contrast-induced nephropathy, making this approach relevant but not entirely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1- Inpatients and outpatients aged 18years and above who underwent single intravenous Contrast procedures. Exclusion criteria: 1. Patients below 18 years, failure to obtain consent. 2. Patients with ESRD/ on maintenance hemodialysis. 3. New-York Heart Association class IV Congestive Cardiac Failure (CCF) or patients with cardiogenic shock . 4. History of hypersensitivity to contrast in the past or exposure to contrast in the last 24-48 hours, 5-nursing/pregnant subjects. 5. Patients with malignancy or other organ failure like decompensated liver cirrhosis
Where it's running
-
Sohag university hospitals
Sohag, Egypt Recruiting -
Sohag university hospitals
Sohag, Egypt Recruiting
Study contacts
- Study coordinator: Esraa R Youssef, Resident
- Email: esraa_ragab_post@med.sohag.edu.eg
- Phone: +201121932876
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.